Principia
CDP Venture Capital leads €15m series-C for Wise
Indaco and Eureka also take part in the round, alongside previous backers including Principia and HTGF
Omnes, Principia, Seventure in €46.3m series-E for Enterome
New investors SymBiosis and Takeda Pharmaceutical Company also take part in the round
Principia backs laser specialist Lambda
Company management retains the remaining minority holding and stays on with the business
Principia sells Comecer to trade
ATS also acquires a majority stake from the Zanelli family for a total purchase price of €113m
Principia backs Gada
Company's management will retain the remaining minority holding and continue to lead the business
Principia invests €7m in Comftech
Company plans to use the fresh capital to launch its products on the European and US markets
Principia backs CrestOptics
VC firm deployed capital from its healthcare-dedicated vehicle Principia III – Health
Principia leads €10m series-A for CheckMab
GP deploys capital from its healthcare-dedicated vehicle Principia III to finance the investment
Principia et al. in €32m series-D round for Enterome
Company also nets a €40m credit line provided by the European Investment Bank
Vivocha sold to Aksía's Covisian
Deal sees Italian venture capital houses Principia and Vertis fully exit the business
Principia invests in Gemelli Clinical Trial Center
GP provides capital via its healthcare-dedicated fund, Principia III – Health
Principia launches fifth VC fund, Utopia
GP is also currently on the market raising funds for its fashion- and design-dedicated fourth vehicle
Principia backs Trifarma MBO
Deal is the first majority acquisition for the GP's healthcare-dedicated vehicle, Principia III Health
Principia leads €6.5m series-B for neurology firm Wise
Existing investors Atlante Ventures, High-Tech Gründerfonds, F3F and Antares join the round
Principia launches fashion- and design-focused VC fund
Launched with a €150m target, the fund expects to close its first transaction by Q3 2017
Invitalia and Principia lead €1.4m series-A for Pedius
Funding round backers include Invitalia Ventures, Pricipia and existing investor TIM Ventures
Principia buys 49% stake in Rigenerand for €8.7m
Deal marks the fourth transaction for the Principia III-Health venture capital vehicle
Principia invests €7m in Silk Biomaterials
Deal marks the third transaction of the biomedical- and healthcare-focused Principia III fund
Principia's Applix bolts on Melazeta
Third acquisition in five years for Applix, which will focus on digital entertainment
Principa divests Docebo to Klass
Investment will be used to support US expansion
Italian VC ecosystem shows signs of maturity
New laws aimed at start-ups as well as recent fund closes signal Italian VC is maturing
Sofinnova Partners et al. sell EOS for up to €310m
Sofinnova Partners, Aescap Venture and Principia have sold Milan-based cancer therapeutics firm Ethical Oncology Science (EOS) to Clovis Oncology via an agreement that could see the firm fetch up to €310m.
Principia backs Rysto with $1m
Italian venture capital firm Principia has injected $1m into Rysto, an online portal for jobseekers in hospitality and catering.
Principia backs Weekend-a-gogo
Italian VC player Principia has injected €450,000 into Neapolitan social tourism platform Weekend-a-gogo.